124 related articles for article (PubMed ID: 8448601)
1. Investigations into the mechanism of vasoconstrictor action of the topical steroid betamethasone-17-valerate in the rat.
Ahluwalia A; Flower RJ
Br J Pharmacol; 1993 Feb; 108(2):544-8. PubMed ID: 8448601
[TBL] [Abstract][Full Text] [Related]
2. Topical betamethasone-17-valerate inhibits heat-induced vasodilatation in man.
Ahluwalia A; Flower RJ
Br J Dermatol; 1993 Jan; 128(1):45-8. PubMed ID: 8427821
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the effects of captopril and enalapril on skin responses to intradermal bradykinin and skin blood flow in the human forearm.
Li Kam Wa TC; Cooke ED; Turner P
Br J Clin Pharmacol; 1993 Jan; 35(1):8-13. PubMed ID: 8448072
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
Vianna RM; Calixto JB
Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
[TBL] [Abstract][Full Text] [Related]
5. Effect of a calcitonin gene-related peptide antagonist (CGRP8-37) on skin vasodilatation and oedema induced by stimulation of the rat saphenous nerve.
Escott KJ; Brain SD
Br J Pharmacol; 1993 Oct; 110(2):772-6. PubMed ID: 8242250
[TBL] [Abstract][Full Text] [Related]
6. Endotoxin-induced vasodilatation in anaesthetized rat skin involves nitric oxide and prostaglandin synthesis.
Warren JB; Coughlan ML; Williams TJ
Br J Pharmacol; 1992 Aug; 106(4):953-7. PubMed ID: 1382790
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of B1 receptor mediating des-Arg9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin.
Campos MM; Souza GE; Calixto JB
Br J Pharmacol; 1996 Mar; 117(5):793-8. PubMed ID: 8851492
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the bioactivity of mometasone furoate 0.1% fatty cream, betamethasone dipropionate 0.05% cream and betamethasone valerate 0.1% cream in humans. Inhibition of UV-B-induced inflammation monitored by laser Doppler blood flowmetry.
Bjerring P
Skin Pharmacol; 1993; 6(3):187-92. PubMed ID: 8274288
[TBL] [Abstract][Full Text] [Related]
9. Effect of chronic capsaicin and guanethidine treatment on skin blood flow of the rat.
Ahluwalia A; Flower RJ
Agents Actions; 1993; 38 Spec No():C16-8. PubMed ID: 8317312
[TBL] [Abstract][Full Text] [Related]
10. An investigation into the mechanism of capsaicin-induced oedema in rabbit skin.
Newbold P; Brain SD
Br J Pharmacol; 1995 Feb; 114(3):570-7. PubMed ID: 7537589
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of captopril on regional haemodynamic responses to angiotensin I and bradykinin in conscious rats.
Gardiner SM; Kemp PA; Bennett T
Br J Pharmacol; 1993 Mar; 108(3):769-75. PubMed ID: 8467363
[TBL] [Abstract][Full Text] [Related]
12. Steroid inhibition of oedema formation in the rat skin.
Ahluwalia A; Peers SH; Flower RJ
Br J Pharmacol; 1992 Jul; 106(3):628-31. PubMed ID: 1504745
[TBL] [Abstract][Full Text] [Related]
13. The role of B1 and B2 kinin receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG).
Campos MM; Henriques MG; Calixto JB
Br J Pharmacol; 1997 Feb; 120(3):502-8. PubMed ID: 9031756
[TBL] [Abstract][Full Text] [Related]
14. Effect of captopril on skin blood flow following intradermal bradykinin measured by laser Doppler flowmetry.
Li Kam Wa TC; Almond NE; Cooke ED; Turner P
Eur J Clin Pharmacol; 1989; 37(5):471-5. PubMed ID: 2532136
[TBL] [Abstract][Full Text] [Related]
15. Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 1. Dermal atrophy.
Young JM; Yoxall BE; Wagner BM
Br J Dermatol; 1978 Dec; 99(6):655-63. PubMed ID: 737128
[TBL] [Abstract][Full Text] [Related]
16. Captopril increases skin microvascular blood flow secondary to bradykinin, nitric oxide, and prostaglandins.
Warren JB; Loi RK
FASEB J; 1995 Mar; 9(5):411-8. PubMed ID: 7896012
[TBL] [Abstract][Full Text] [Related]
17. Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism.
Zanzinger J; Zheng X; Bassenge E
Cardiovasc Res; 1994 Feb; 28(2):209-14. PubMed ID: 8143302
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous blood flow changes and weal induced by intradermal bradykinin following pretreatment with indomethacin and captopril.
Wa TC; Cooke ED; Turner P
Eur J Clin Pharmacol; 1993; 44(1):41-5. PubMed ID: 8436153
[TBL] [Abstract][Full Text] [Related]
19. Topical betamethasone 17-valerate is an anticorticosteroid in the rat. 2. Anti-inflammatory and anti-lymphocyte activities.
Young JM; Wagner BM; Fisk RA
Br J Dermatol; 1978 Dec; 99(6):665-73. PubMed ID: 737129
[TBL] [Abstract][Full Text] [Related]
20. Antinociceptive profile of the pseudopeptide B2 bradykinin receptor antagonist NPC 18688 in mice.
CorrĂȘa CR; Kyle DJ; Chakraverty S; Calixto JB
Br J Pharmacol; 1996 Feb; 117(3):552-558. PubMed ID: 8821548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]